Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group

Scand J Urol Nephrol. 1997 Jun;31(3):249-54. doi: 10.3109/00365599709070342.

Abstract

The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Humans
  • Male
  • Orchiectomy*
  • Premedication*
  • Prostate / pathology
  • Prostatectomy
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery
  • Randomized Controlled Trials as Topic
  • Testis / pathology
  • Testosterone / analogs & derivatives
  • Testosterone / metabolism

Substances

  • Androgen Antagonists
  • Testosterone
  • boldenone